Clinical and Economic Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with TPO-Ras and Rituximab

Background Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by reduced platelet counts. Patients with ITP lasting for ≥3 months (persistent or chronic primary ITP), and who do not respond adequately or maintain a response to initial therapy, are usually treated with adva...

Full description

Bibliographic Details

Published in:	Blood Vol. 142; no. Supplement 1; p. 3953
Main Authors:	Kuter, David J, Umarje, Siddhi, Gouia, Imene, Cordoba, Matias, Ward, Brad, Hemim, Ines, Petruski-Ivleva, Natalia
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 02-11-2023
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!